Clinical Trials Directory

Trials / Completed

CompletedNCT03310450

Tour de Borobudur Troponin Study on Predictors and Synergistic Role of MDA and Hs-CRP Levels

Predictors of Cardiac Troponin Release After Tour de Borobudur 2017

Status
Completed
Phase
Study type
Observational
Enrollment
94 (actual)
Sponsor
Universitas Negeri Semarang · Academic / Other
Sex
Male
Age
25 Years – 55 Years
Healthy volunteers
Accepted

Summary

Prospective observational study to determine predictors that related to cardiac troponin I (cTnI) release, malondialdehyde (MDA) and high sensitivity C Reactive Protein (hs-CRP) after Tour de Borobudur (TdB) 2017

Detailed description

Eligible Criteria: 1. minimum sample size of 80 men, non-athlete, participants of TdB 2. Classified into two groups: 160kms cycling and 100kms cycling participation 3. 25-55 years old 4. voluntary participate in the research 5. eligible in pre participatory physical examination and ECG test by the doctor 6. have no history of the previous acute coronary syndrome (ACS) Measurements: Interview for determining predictors of sports participation history, medical history, family medical history and Rate of Perceived Exertion Measurement and examination to determine: anthropometry parameters, clinical conditions (Systolic BP, Diastolic BP, hemoglobin levels, T-cholesterol and HDL-C levels, the intensity in cycling activities (mileage, velocity, duration, and time for resting), hemodynamic responses (average and maximum heart rate, Karvonen Index), and Hydration status Other outcome measurements; pre and post-TdB 2017 measurements of cTnI, MDA, and hs-CRP

Conditions

Interventions

TypeNameDescription
OTHER140kms cyclingMain exposure is long distance cycling touring (TdB/NC) consists of three groups; 140kms, 100kms, and 240kms (investigator did not give any treatment/intervention, just observed the cycling touring event)

Timeline

Start date
2017-10-28
Primary completion
2017-11-11
Completion
2018-05-05
First posted
2017-10-16
Last updated
2019-10-10
Results posted
2019-10-02

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT03310450. Inclusion in this directory is not an endorsement.